JAMA

One-year access to more than 500 world journals available in the system

Duration of Time : 365 Day
~~Price : 300$~~
Special Price : 100$

Order

Effect of e-Cigarettes Plus Counseling vs Counseling Alone on Smoking Cessation

Mark J. Eisenberg, MD, MPH1,2,3; Andréa Hébert-Losier, MSc1; Sarah B. Windle, MPH1; Todd Greenspoon, MD4; Tim Brandys, MD5; Tamàs Fül?p, MD, PhD6; Thang Nguyen, MD7; Stéphane Elkouri, MD8; Martine Montigny, MD9; Igor Wilderman, MD10; Olivier F. Bertrand, MD, PhD11; Joanna Alexis Bostwick, MD12; John Abrahamson, MD13; Yves Lacasse, MD11; Smita Pakhale, MD14; Josselin Cabaussel, MSc1; Kristian B. Filion, PhD1,2; for the E3 Investigators

doi : 10.1001/jama.2020.18889

JAMA. 2020;324(18):1844-1854

Electronic cigarettes (e-cigarettes) for smoking cessation remain controversial.

Buy The Package and View The Article Online

Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults

Heike A. Bischoff-Ferrari, MD, DrPH1,2,3; Bruno Vellas, MD, PhD4,5; René Rizzoli, MD6; Reto W. Kressig, MD7; José A. P. da Silva, MD, PhD8,9; Michael Blauth, MD10; David T. Felson, MD, MPH11,12; Eugene V. McCloskey, MD13,14; Bernhard Watzl, PhD15; Lorenz C. Hofbauer, MD16,17; Dieter Felsenberg, MD, PhD18; Walter C. Willett, MD19,20; Bess Dawson-Hughes, MD21; JoAnn E. Manson, MD, DrPH22; Uwe Siebert, MD, MPH23,24,25; Robert Theiler, MD2; Hannes B. Staehelin, MD26; Caroline de Godoi Rezende Costa Molino, PhD1; Patricia O. Chocano-Bedoya, MD, PhD1; Lauren A. Abderhalden, PhD1; Andreas Egli, MD1; John A. Kanis, MD27,28; Endel J. Orav, PhD29; for the DO-HEALTH Research Group

doi : 10.1001/jama.2020.16909

JAMA. 2020;324(18):1855-1868

The benefits of vitamin D, omega-3 fatty acids, and exercise in disease prevention remain unclear.

Buy The Package and View The Article Online

Association of Skilled Nursing Facility Participation in a Bundled Payment Model With Institutional Spending for Joint Replacement Surgery

Michael L. Barnett, MD, MS1,2; Karen E. Joynt Maddox, MD, MPH3,4; E. John Orav, PhD1,2; David C. Grabowski, PhD5; Arnold M. Epstein, MD, MA1,2

doi : 10.1001/jama.2020.19181

JAMA. 2020;324(18):1869-1877

Medicare recently concluded a national voluntary payment demonstration, Bundled Payments for Care Improvement (BPCI) model 3, in which skilled nursing facilities (SNFs) assumed accountability for patients’ Medicare spending for 90 days from initial SNF admission. There is little evidence on outcomes associated with this novel payment model.

Buy The Package and View The Article Online

Gastrointestinal Complications in Critically Ill Patients With and Without COVID-19

Mohamad El Moheb, MD1; Leon Naar, MD1; Mathias A. Christensen, BSc1; Carolijn Kapoen, BSc1; Lydia R. Maurer, MD1; Maha Farhat, MD, MSc2; Haytham M. A. Kaafarani, MD, MPH1

doi : 10.1001/jama.2020.19400

JAMA. 2020;324(18):1899-1901

Buy The Package and View The Article Online

Preprint Servers’ Policies, Submission Requirements, and Transparency in Reporting and Research Integrity Recommendations

Mario Mali?ki, MD, MA, PhD1; Ana Jeron?i?, MSc, PhD2; Gerben ter Riet, MD, PhD3; Lex M. Bouter, MSc, PhD4; John P. A. Ioannidis, MD, DSc1; Steven N. Goodman, MD, PhD5; IJsbrand Jan Aalbersberg, MSc, PhD6

doi : 10.1001/jama.2020.17195

JAMA. 2020;324(18):1901-1903

Buy The Package and View The Article Online

Submissions and Downloads of Preprints in the First Year of medRxiv

Harlan M. Krumholz, MD, SM1; Theodora Bloom, PhD2; Richard Sever, PhD3; Claire Rawlinson, BSc2; John R. Inglis, PhD3; Joseph S. Ross, MD, MHS4

doi : 10.1001/jama.2020.17529

JAMA. 2020;324(18):1903-1905

Buy The Package and View The Article Online

Screening for High Blood Pressure in Children and Adolescents

US Preventive Services Task Force

doi : 10.1001/jama.2020.20122

JAMA. 2020;324(18):1878-1883

Prevalence of hypertension (both primary and secondary) in children and adolescents in the US ranges from 3% to 4%. Primary hypertension in children and adolescents occurs primarily in children older than 13 years and has no known cause but is associated with several risk factors, including family history and higher body mass index. Secondary hypertension occurs primarily in younger children and is most commonly caused by genetic disorders, renal disease, endocrine disorders, or cardiovascular abnormalities.

Buy The Package and View The Article Online

Screening for Hypertension in Children and Adolescents

Gerald Gartlehner, MD, MPH1,2,3; Emily B. Vander Schaaf, MD, MPH1,4; Colin Orr, MD1,4; Sara M. Kennedy, MPH1,2; Rachel Clark, BA1; Meera Viswanathan, PhD1,2

doi : 10.1001/jama.2020.11119

JAMA. 2020;324(18):1884-1895

Childhood hypertension can result in adverse outcomes during adulthood; identifying and treating primary and secondary childhood hypertension may reduce such risks.

Buy The Package and View The Article Online